XML 16 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Loss $ (5,716,000) $ (4,894,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 195,000 188,000
Deferred tax benefit 0 (26,000)
Stock-based compensation 963,000 693,000
Non-cash patent write-off 8,000 0
Changes in assets and liabilities:    
Accounts receivable (95,000) 11,000
Prepaids and other current assets 80,000 (63,000)
Restricted cash (100,000) 0
Other assets 0 (14,000)
Accounts payable 403,000 123,000
Accrued expenses (79,000) 43,000
Accrued salaries and payroll related expenses (526,000) (8,000)
Customer deposits 130,000 0
Deferred revenue 0 (36,000)
Deferred taxes (3,000) 7,000
Deferred rent (3,000) 0
Net cash used in operating activities (4,737,000) (3,990,000)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchases of property and equipment (519,000) (233,000)
Expenditures for patents and domain names (43,000) (125,000)
Redemption of investments held-to-maturity 0 4,747,000
Purchase of investments held-to-maturity (24,985,000) 0
Net cash provided by (used in) investing activities (25,547,000) 4,389,000
CASH FLOWS FROM FINANCING ACTIVITIES    
Net proceeds from the sale of common stock from private placement offering 0 7,471,000
Net proceeds from the sale of common stock from underwritten public offering 18,381,000 0
Proceeds from exercise of warrants 43,000 0
Net cash provided by financing activities 18,424,000 7,471,000
Effects of exchange rates on cash, cash equivalents and restricted cash 3,000 3,000
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (11,857,000) 7,873,000
CASH, CASH EQUIVALENTS AND RESTRICTED CASH — Beginning of period 19,624,000 5,184,000
CASH, CASH EQUIVALENTS AND RESTRICTED CASH — End of period 7,767,000 13,057,000
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Taxes Paid 3,000 1,000
SUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES    
Issuance of common stock in settlement of liability 0 119,000
Stock options issued in settlement of liability 0 332,000
Restricted stock units issued in settlement of liability 436,000 0
Prepaids included in accounts payable 0 43,000
Property and equipment included in accounts payable 8,000 3,000
Patents included in accounts payable 35,000 36,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]    
Total cash, cash equivalents and restricted cash $ 19,624,000 $ 5,184,000